STOCK TITAN

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

The Merck Foundation has launched a new $17 million initiative called the Collaborative for Equity in Cardiac Care, running from 2025 to 2030. The program aims to improve access to high-quality cardiac care in underserved U.S. communities by transforming primary care delivery, building community partnerships, and addressing social barriers to healthcare. The initiative focuses on helping people with heart conditions who face challenges in accessing timely diagnoses and quality care. Qualified 501(c)(3) non-profit organizations can apply to join the Collaborative by submitting a letter of intent by January 10, 2025.

La Fondazione Merck ha lanciato una nuova iniziativa da 17 milioni di dollari chiamata Collaborative for Equity in Cardiac Care, che si svolgerà dal 2025 al 2030. Il programma mira a migliorare l'accesso a cure cardiache di alta qualità nelle comunità statunitensi svantaggiate attraverso la trasformazione della vendita di assistenza primaria, la creazione di partenariati comunitari e l'affrontare le barriere sociali all'assistenza sanitaria. L'iniziativa si concentra sull'aiutare le persone con condizioni cardiache che affrontano difficoltà nell'accedere a diagnosi tempestive e cure di qualità. Le organizzazioni non profit qualificate 501(c)(3) possono fare domanda per unirsi al Collaborative presentando una lettera di intenti entro il 10 gennaio 2025.

La Fundación Merck ha lanzado una nueva iniciativa de 17 millones de dólares denominada Colaborativo por la Equidad en el Cuidado Cardiaco, que se llevará a cabo desde 2025 hasta 2030. El programa tiene como objetivo mejorar el acceso a cuidados cardíacos de alta calidad en comunidades de EE. UU. desatendidas mediante la transformación de la atención primaria, la construcción de asociaciones comunitarias y la superación de barreras sociales para la salud. La iniciativa se centra en ayudar a las personas con afecciones cardíacas que enfrentan desafíos para acceder a diagnósticos oportunos y atención de calidad. Las organizaciones sin fines de lucro calificadas 501(c)(3) pueden postularse para unirse al Colaborativo presentando una carta de intención antes del 10 de enero de 2025.

머크 재단은 2025년부터 2030년까지 진행되는 1,700만 달러 규모의 새로운 이니셔티브인 심장 치료의 형평성을 위한 협력체를 시작했습니다. 이 프로그램은 기본 진료 전달 방식을 혁신하고, 지역 사회 파트너십을 구축하며, 의료 접근을 방해하는 사회적 장벽을 해결하여 의료 서비스가 부족한 미국 지역 사회에서 고품질 심장 치료의 접근성을 개선하는 것을 목표로 하고 있습니다. 이 이니셔티브는 시기적절한 진단 및 양질의 치료 접근에 어려움을 겪고 있는 심장 질환 환자를 돕는 데 중점을 두고 있습니다. 자격을 갖춘 501(c)(3) 비영리 단체는 2025년 1월 10일까지 의향서를 제출하여 협력체에 가입할 수 있습니다.

La Fondation Merck a lancé une nouvelle initiative de 17 millions de dollars appelée Collaboratif pour l'Équité en Soins Cardiaques, qui se déroulera de 2025 à 2030. Ce programme vise à améliorer l'accès à des soins cardiaques de haute qualité dans les communautés mal desservies des États-Unis en transformant la prestation des soins primaires, en construisant des partenariats communautaires et en abordant les barrières sociales à l’accès aux soins. L'initiative se concentre sur l'aide aux personnes atteintes de maladies cardiaques qui rencontrent des défis pour accéder à des diagnostics opportuns et à des soins de qualité. Les organisations à but non lucratif qualifiées 501(c)(3) peuvent postuler pour rejoindre le Collaboratif en soumettant une lettre d'intention d'ici le 10 janvier 2025.

Die Merck-Stiftung hat eine neue Initiative in Höhe von 17 Millionen Dollar ins Leben gerufen, die Kooperationsprogramm für Chancengleichheit in der herzmedizinischen Versorgung heißt und von 2025 bis 2030 läuft. Das Programm zielt darauf ab, den Zugang zu hochwertiger herzmedizinischer Versorgung in unterversorgten Gemeinschaften in den USA zu verbessern, indem die primäre Versorgung transformiert, Gemeinschaftspartnerschaften aufgebaut und soziale Barrieren im Gesundheitswesen angegangen werden. Die Initiative konzentriert sich darauf, Menschen mit Herzerkrankungen zu helfen, die Schwierigkeiten haben, rechtzeitige Diagnosen und hochwertige Pflege zu erhalten. Qualifizierte 501(c)(3)-Non-Profit-Organisationen können einen Antrag stellen, um dem Kooperativen Programm beizutreten, indem sie bis zum 10. Januar 2025 ein Absichtsschreiben einreichen.

Positive
  • Commitment of $17 million in funding over five years (2025-2030)
Negative
  • None.

RAHWAY, NJ / ACCESSWIRE / November 20, 2024 / The Merck Foundation (Foundation) has announced a new initiative to help advance equitable access to high-quality, culturally responsive care for people with heart conditions in underserved U.S. communities-the Collaborative for Equity in Cardiac Care (Collaborative).

The Foundation is committing $17 million over five years (2025-2030) to support the Collaborative, which aims to:

  • Transform the delivery of primary care by promoting person-centered approaches to meet the medical and social needs of people living with heart conditions;

  • Build sustainable community partnerships to address barriers to cardiac care;

  • Improve health outcomes and quality of life for people living with heart conditions;

  • Disseminate findings and lessons learned to improve the delivery of cardiac care.

In underserved communities across the U.S., people with heart conditions encounter more barriers to timely diagnoses, receive a lower quality of care and experience poorer health outcomes than those living in other parts of the country. These disparities are often fueled by social drivers of health, such as a lack of access to stable housing, transportation, education, nutritious foods and employment opportunities.

To apply to join the Collaborative and help address inequities in cardiac care, an organization must be designated as a qualified 501(c)(3) non-profit organization and submit a letter of intent to cardiaccareequity@rabinmartin.com by Jan.10, 2025. For more information, please click here to view the Collaborative's call for proposals.

About the Merck Foundation

The Merck Foundation (Foundation) is a U.S.-based, private charitable organization. Established in 1957 by Merck, a leading global biopharmaceutical company, the Foundation is funded entirely by the company and is Merck's chief source of funding support to qualified non-profit charitable organizations. Since its inception, the Foundation has contributed more than $1 billion to support important initiatives that address critical global health and societal needs that are consistent with Merck's purpose: to save and improve lives around the world. For more information, visit merck.com/company-overview/sustainability/philanthropy/merck-foundation.

View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.

Contact Info:

Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com

SOURCE: Merck & Co., Inc.



View the original press release on accesswire.com

FAQ

What is the value of Merck Foundation's new cardiac care initiative?

The Merck Foundation is committing $17 million over five years (2025-2030) to the Collaborative for Equity in Cardiac Care initiative.

When is the deadline to apply for Merck's (MRK) Collaborative for Equity in Cardiac Care?

The deadline to submit a letter of intent for the Collaborative is January 10, 2025.

What are the eligibility requirements for Merck's (MRK) cardiac care initiative?

Organizations must be designated as qualified 501(c)(3) non-profit organizations to be eligible for the Collaborative.

Merck & Co., Inc.

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Stock Data

246.80B
2.53B
0.06%
79.47%
1.04%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
KENILWORTH